These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26753456)

  • 1. Association of IL-1β and IL-10 Polymorphisms with Prostate Cancer Risk and Grade of Disease in Eastern Croatian Population.
    Horvat V; Mandić S; Marczi S; Mrčela M; Galić J
    Coll Antropol; 2015 Jun; 39(2):393-400. PubMed ID: 26753456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association study of cytochrome P450 1A1*2A polymorphism with prostate cancer risk and aggressiveness in Croatians.
    Mandić S; Horvat V; Marczi S; Lukić I; Galić J
    Coll Antropol; 2014 Mar; 38(1):141-6. PubMed ID: 24851608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer.
    Ianni M; Porcellini E; Carbone I; Potenzoni M; Pieri AM; Pastizzaro CD; Benecchi L; Licastro F
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):56-61. PubMed ID: 22850906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Interleukin-6 Single Nucleotide Polymorphism and Susceptibility to Prostate Adenocarcinoma and Bone Metastasis in an Iranian Population.
    Dargahi Abbasabad G; Banan Khojasteh SM; Eskandari Naji H; Zamani MR; Hajipour H; Serati-Nouri H
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1717-1720. PubMed ID: 29938471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between interleuleukin-1β polymorphism (rs16944) and biomarkers levels in Iraqi patients with prostate cancer.
    Abed AS; Mokdad-Gargouri R; Raoof WM
    Mol Biol Rep; 2023 Feb; 50(2):1157-1165. PubMed ID: 36417078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
    Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
    BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
    Gunes S; Bagci H; Sarikaya S; Bilen CY; Kara N
    DNA Cell Biol; 2007 Dec; 26(12):873-8. PubMed ID: 17961073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of SNPs/haplotypes in promoter of TNF A and IL-10 gene together with life style factors in prostate cancer progression in Indian population.
    Bandil K; Singhal P; Dogra A; Rawal SK; Doval DC; Varshney AK; Bharadwaj M
    Inflamm Res; 2017 Dec; 66(12):1085-1097. PubMed ID: 28993831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
    Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
    Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between TNF-alpha promoter polymorphism and prostate carcinoma susceptibility in eastern Croatian population.
    Horvat V; Sudarević B; Cosić I; Milicević N; Bosnjak S; Mandić S; Marczi S; Simunović D; Galić J
    Coll Antropol; 2013 Dec; 37(4):1199-202. PubMed ID: 24611335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenetics of prostate cancer and benign hyperplasia--the potential use of an HLA-G variant as a tag SNP for prostate cancer risk.
    Zambra FM; Biolchi V; de Cerqueira CC; Brum IS; Castelli EC; Chies JA
    HLA; 2016 Feb; 87(2):79-88. PubMed ID: 26889902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin (IL)-8 polymorphisms and risk of prostate disorders.
    Taheri M; Noroozi R; Dehghan A; Roozbahani GA; Omrani MD; Ghafouri-Fard S
    Gene; 2019 Apr; 692():22-25. PubMed ID: 30641210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCR2 and CCR5 genes polymorphisms in benign prostatic hyperplasia and prostate cancer.
    Zambra FM; Biolchi V; Brum IS; Chies JA
    Hum Immunol; 2013 Aug; 74(8):1003-8. PubMed ID: 23632061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of caspases with an increased prostate cancer risk in north Indian population.
    Mittal RD; Mittal T; Singh AK; Mandal RK
    DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of interleukin gene polymorphisms with the risk of coronary artery disease.
    Yang HT; Wang SL; Yan LJ; Qian P; Duan HY
    Genet Mol Res; 2015 Oct; 14(4):12489-96. PubMed ID: 26505399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.
    Samzadeh M; Hasanzad M; Jamaldini SH; Haghdoost AA; Afshari M; Ziaee SA
    Urol J; 2012; 9(4):691-9. PubMed ID: 23235975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic Polymorphism of MMP2 Gene and Susceptibility to Prostate Cancer.
    Adabi Z; Mohsen Ziaei SA; Imani M; Samzadeh M; Narouie B; Jamaldini SH; Afshari M; Safavi M; Roshandel MR; Hasanzad M
    Arch Med Res; 2015 Oct; 46(7):546-50. PubMed ID: 26319608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.
    Dwivedi S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK
    Cytokine; 2015 Jul; 74(1):117-22. PubMed ID: 25892571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPINK1 Promoter Variants Are Associated with Prostate Cancer Predisposing Alterations in Benign Prostatic Hyperplasia Patients.
    Winchester D; Ricks-Santi L; Mason T; Abbas M; Copeland RL; Beyene D; Jingwi EY; Dunston GM; Kanaan YM
    Anticancer Res; 2015 Jul; 35(7):3811-9. PubMed ID: 26124326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.